Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study
2007

Comparing Blood Pressure Medications in Obese Diabetic Patients

Sample size: 840 publication 10 minutes Evidence: high

Author Information

Author(s): Arya M Sharma, Jaime Davidson, Stephen Koval, Yves Lacourcière

Primary Institution: McMaster University

Hypothesis

Is telmisartan combined with hydrochlorothiazide more effective than valsartan combined with hydrochlorothiazide in reducing blood pressure in obese hypertensive patients with type 2 diabetes?

Conclusion

Telmisartan combined with hydrochlorothiazide significantly lowers blood pressure more effectively than valsartan combined with hydrochlorothiazide in high-risk patients.

Supporting Evidence

  • Telmisartan provided greater reductions in blood pressure compared to valsartan.
  • Both treatments were well tolerated with low incidence of adverse events.
  • Significant differences in blood pressure control were observed during the early morning hours.

Takeaway

This study found that one type of blood pressure medicine works better than another for people who are overweight and have diabetes.

Methodology

A randomized, open-label, multicentre trial comparing the effects of telmisartan and valsartan on blood pressure using ambulatory monitoring.

Potential Biases

Potential bias in patient selection and reporting of outcomes.

Limitations

The study may not be generalizable to all populations due to specific inclusion and exclusion criteria.

Participant Demographics

Patients were aged 30 and older, with a mix of genders and races, primarily overweight or obese with type 2 diabetes.

Statistical Information

P-Value

p < 0.0001

Confidence Interval

95% CI -5.8, -2.1

Statistical Significance

p < 0.0001

Digital Object Identifier (DOI)

10.1186/1475-2840-6-28

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication